Skip to Main Content
Table 3

Deficient NERC and human CaP risk

NERCControlCaseCrude OR (95% CI)Adjusted OR (95% CI)a
Median cut-offb     
 High (≥8.7%) 48 50 1.00 (Ref.) 1.00 (Ref.) 
 Low (<8.7%) 48 90 1.80 (1.06–3.05) 2.14 (1.19–3.86) 
Quartilesb     
 12.10% + 23 26 1.00 (Ref.) 1.00 (Ref.) 
 8.7% + to 12.10% 25 24 0.85 (0.38–1.88) 1.09 (0.46–2.59) 
 5.78% + to 8.7% 24 36 1.33 (0.62–2.84) 1.81 (0.77–4.27) 
 <5.78% 24 54 1.99 (0.95–4.17) 2.63 (1.17–5.95)c 
NERCControlCaseCrude OR (95% CI)Adjusted OR (95% CI)a
Median cut-offb     
 High (≥8.7%) 48 50 1.00 (Ref.) 1.00 (Ref.) 
 Low (<8.7%) 48 90 1.80 (1.06–3.05) 2.14 (1.19–3.86) 
Quartilesb     
 12.10% + 23 26 1.00 (Ref.) 1.00 (Ref.) 
 8.7% + to 12.10% 25 24 0.85 (0.38–1.88) 1.09 (0.46–2.59) 
 5.78% + to 8.7% 24 36 1.33 (0.62–2.84) 1.81 (0.77–4.27) 
 <5.78% 24 54 1.99 (0.95–4.17) 2.63 (1.17–5.95)c 
a

Odds ratio adjusted for age, race, smoking history, BPH, and FH.

b

Values of controls were used as cut-off.

c

P = 0.01, test for linear trend.

Close Modal

or Create an Account

Close Modal
Close Modal